Accounts Payable / Remittance Processing

WHITE PAPERS AND CASE STUDIES

• Side-Stream SDOX® Systems Enhance Biological Function And Treatment Capacity

  Wastewater from the meat processing facility is treated using a sequence batch reactor and an aerobic lagoon that discharges to surface waters following treatment. The facility replaced surface aeration equipment with two, 350-HP the “no-splash,” side-stream SDOX® systems retrofitted to the treatment basin. Read the full case study to learn the results.

• Crusher Takes Its Lumps, Minimizes Elbow Grease

  CCP, Inc. in West Paterson, N.J. makes over 1,000 product formulations under private labels for the cosmetics industry, using materials such as persulfates, alkali silicates, phosphates, sodium chloride, and magnesium chloride.

• Developing A Disposable Grade-A Aseptic Fill/Finish Isolation System

  Isolation of aseptic processes is not a new technology. Flexible film isolation has been used in aseptic processing since the 1970s, but these systems tended to be a composite of stainless-steel chambers and airflow modules with a flexible film user interface. 

• Strategies For Developing Xilinx’s Zynq UltraScale+ RFSoC

  New RFSoC technologies add RF-class analog-to-digital and digital-to-analog data converters to Xilinx’s family of FPGAs. This white paper looks at current trends in data converters and signal processing to better understand the capabilities of RFSoC and how to best use the technology.

• A Hand-On Guide To Customer Engagement In Service Delivery

  When we assess customer service effectiveness in a company, we focus mostly on KPIs based on time – SLA compliance, mean time to complete a work order, and number of orders per day. However, time should be perceived as a key driver of service development, not only as one efficiency indicator.

• In-Situ, Non-Destructive Surface Area Measurement For The Optimal Application Of Lyophilization

  A key focus of this paper is the relevant measurement of surface area, with experimental data demonstrating the performance and value of novel instrumentation for in-situ characterization.

• Braving The Complexities Of Immuno-Oncology Trials

  Immuno-oncology trials are increasing in prevalence and, for many reasons, are much more complex than standard clinical trials. Learn how partnering with an experienced central lab can alleviate these challenges, create efficiencies and save researchers time and expense.

• 3 Development Principles For Advanced Biopharma Tubing: Part 1

  Tubing is arguably one of the earliest components in pharma to be associated with single-use technology. This paper espouses active risk mitigation and cleaner materials in single-use tubing applications.

• Regulatory Perspective: Digital Health Technology Tools

  Digital health technology tools (DHTTs) can help capture patient experiences in real world settings. In addition to providing richer and more comprehensive information on how patients are functioning and feeling, DHTTs can help minimize barriers to obtaining patient experience data during clinical investigations. Read how these novel approaches and tools can support regulatory decision-making.

• Solid Dose Manufacturer Installs Serialization Efforts For Compliance

  Artesan Pharma demonstrates how an effective program of serialization, i.e. the traceability of medicines, can successfully be put into practice in today's pharmaceutical industry.

• Laser Measurements In Materials Processing: How And When They Absolutely, Positively Must Be Made

  When improving laser-based processes, there are a variety of parameters that must be measured. Additionally, the continuously rising power of laser systems in material processing makes the requirements for laser measurement systems more challenging than ever. This white paper discusses laser measurements in materials processing as well as how and when they must be made for the best results.

• Addressing The Evolving Information And Automation Needs Of Biopharma

  A dramatic increase in the information available, in parallel with a reduction in the cost of obtaining, processing, and transmitting information, is changing the way biopharma manufacturers operate.